by EmpathiCSubstanceS | Aug 11, 2022 | Psychedelic Research
Analyses of the interviews revealed that the music had both “welcome” and “unwelcome” influences on patients’ subjective experiences. Welcome influences included the evocation of personally meaningful and therapeutically useful emotion...
by EmpathiCSubstanceS | Aug 11, 2022 | Psychedelic Medicine
Patients showed a significant pessimism bias at baseline [t(14) = -3.260, p = 0.006; 95% CI (-0.16, -0.03), g = 1.1] which was related to the severity of their depressive symptoms (rs = -0.55, p = 0.017). One week after psilocybin treatment, this bias was...
by EmpathiCSubstanceS | Aug 11, 2022 | Psychedelic Research
Nature relatedness significantly increased (t(6)=−4.242, p=0.003) and authoritarianism significantly decreased (t(6)=2.120, p=0.039) for the patients 1 week after the dosing sessions. At 7–12 months post-dosing, nature relatedness remained significantly increased...
by EmpathiCSubstanceS | Aug 11, 2022 | Psychedelic Research
Speech analytics and machine learning successfully differentiated depressed patients from healthy controls and identified treatment responders from non-responders with a significant level of 85% of accuracy (75% precision). Conclusions: Automatic natural language...
by EmpathiCSubstanceS | Aug 11, 2022 | Psychedelic Research
Group results revealed rapid and enduring improvements in depressive symptoms post psilocybin. Increased responses to fearful and happy faces were observed in the right amygdala post-treatment, and right amygdala increases to fearful versus neutral faces were...
